Read + Share
Amedeo Smart
Independent Medical Education
Iyengar AR, Downs EP, Mehta S, Rangarajan N, et al. HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0. Breast J 2026;2026:e7212120.PMID: 42340017
Email
LinkedIn
Privacy Policy